| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 5609 | 2008 |
| Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis R Herbrecht, DW Denning, TF Patterson, JE Bennett, RE Greene, ... New England Journal of Medicine 347 (6), 408-415, 2002 | 3838 | 2002 |
| Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America JR Perfect, WE Dismukes, F Dromer, DL Goldman, JR Graybill, RJ Hamill, ... Clinical infectious diseases 50 (3), 291-322, 2010 | 3077 | 2010 |
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ... Проблемы медицинской микологии 5 (1), 10-16, 2003 | 2890 | 2003 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1891 | 2020 |
| Epidemiology and clinical manifestations of mucormycosis G Petrikkos, A Skiada, O Lortholary, E Roilides, TJ Walsh, ... Clinical Infectious Diseases 54 (suppl_1), S23-S34, 2012 | 1540 | 2012 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1303 | 2012 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1281 | 2018 |
| Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome a prospective study in 342 patients L Guillevin, F Lhote, M Gayraud, P Cohen, B Jarrousse, O Lortholary, ... Medicine 75 (1), 17-28, 1996 | 1213 | 1996 |
| Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria P Valent, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, ... European journal of clinical investigation 37 (6), 435-453, 2007 | 897 | 2007 |
| Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis L Liu, S Okada, XF Kong, AY Kreins, S Cypowyj, A Abhyankar, J Toubiana, ... Journal of Experimental Medicine 208 (8), 1635-1648, 2011 | 880 | 2011 |
| Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 874 | 2016 |
| Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial ER Kuse, P Chetchotisakd, CA da Cunha, M Ruhnke, C Barrios, ... The Lancet 369 (9572), 1519-1527, 2007 | 862 | 2007 |
| Liposomal amphotericin b as initial therapy for invasive mold infection: a randomized trial comparing a high–loading dose regimen with standard dosing (AmBiLoad Trial) OA Cornely, J Maertens, M Bresnik, R Ebrahimi, AJ Ullmann, E Bouza, ... Clinical infectious diseases 44 (10), 1289-1297, 2007 | 826 | 2007 |
| Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign RE Greene, HT Schlamm, JW Oestmann, P Stark, C Durand, O Lortholary, ... Clinical Infectious Diseases 44 (3), 373-379, 2007 | 741 | 2007 |
| Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006) O Leroy, JP Gangneux, P Montravers, JP Mira, F Gouin, JP Sollet, J Carlet, ... Critical care medicine 37 (5), 1612-1618, 2009 | 731 | 2009 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 728 | 2014 |
| European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clin Infect Dis 46 (12), 1813-1821, 2008 | 725 | 2008 |
| Immunoproliferative Small Intestinal Disease Associated with Campylobacter jejuni M Lecuit, E Abachin, A Martin, C Poyart, P Pochart, F Suarez, D Bengoufa, ... New England Journal of Medicine 350 (3), 239-248, 2004 | 630 | 2004 |
| A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007) F Lanternier, E Dannaoui, G Morizot, C Elie, D Garcia-Hermoso, M Huerre, ... Clinical Infectious Diseases 54 (suppl_1), S35-S43, 2012 | 563 | 2012 |
